NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers-Reference-Cited by-同舟云学术

NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers

Published:2013-01 Issue:1 Volume:23 Page:48-62
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Zhou Wen,Yang Ye,Xia Jiliang,Wang He,Salama Mohamed E.,Xiong Wei,Xu Hongwei,Shetty Shashirekha,Chen Tiehua,Zeng Zhaoyang,Shi Lei,Zangari Maurizio,Miles Rodney,Bearss David,Tricot Guido,Zhan Fenghuang

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference49 articles.

1. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation;Avet-Loiseau;Blood,2002

2. beta-Catenin is a Nek2 substrate involved in centrosome separation;Bahmanyar;Genes Dev.,2008

3. Thalidomide and hematopoietic-cell transplantation for multiple myeloma;Barlogie;N. Engl. J. Med.,2006

4. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma;Bergsagel;Blood,2005

5. The subcellular destinations of APC proteins;Bienz;Nat. Rev. Mol. Cell Biol.,2002

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cancer stem cells in multiple myeloma;Trends in Cancer;2024-08

2. Role of NEK2 in tumorigenesis and tumor progression;Trends in Molecular Medicine;2024-08

3. Prognostic value and immune infiltration of the NEK family in clear cell renal cell carcinoma;Medicine;2024-07-19

4. Investigation on the molecular mechanism of SPA interference with osteogenic differentiation of bone marrow mesenchymal stem cells;Scientific Reports;2024-07-06

5. Transcriptome analysis of beta-catenin-related genes in CD34+ haematopoietic stem and progenitor cells from patients with AML;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29